Shigeru Yoshida
Osaka, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Hypersensitivity Events, Including Potentially Hypersensitivity-Related Skin Events, with Dapagliflozin in Patients with Type 2 Diabetes Mellitus: A Pooled Analysis.
Journal: Clinical drug investigation
Published: July 28, 2016
Novel GPR40 agonist AS2575959 exhibits glucose metabolism improvement and synergistic effect with sitagliptin on insulin and incretin secretion.
Journal: Life sciences
Published: August 15, 2013
Chronic treatment with novel GPR40 agonists improve whole-body glucose metabolism based on the glucose-dependent insulin secretion.
Journal: The Journal of pharmacology and experimental therapeutics
Published: July 16, 2013
Synthesis and structure-activity relationship of fused-pyrimidine derivatives as a series of novel GPR119 agonists.
Journal: Bioorganic & medicinal chemistry
Published: July 23, 2012
Novel GPR119 agonist AS1669058 potentiates insulin secretion from rat islets and has potent anti-diabetic effects in ICR and diabetic db/db mice.
Journal: Life sciences
Published: June 15, 2012
Discovery and biological evaluation of novel 4-amino-2-phenylpyrimidine derivatives as potent and orally active GPR119 agonists.
Journal: Bioorganic & medicinal chemistry
Published: June 08, 2012
The therapeutic potential of GPR119 agonists for type 2 diabetes.
Journal: Expert opinion on investigational drugs
Published: February 02, 2012
Synthesis and structure-activity relationship of 4-amino-2-phenylpyrimidine derivatives as a series of novel GPR119 agonists.
Journal: Bioorganic & medicinal chemistry
Published: November 21, 2011
Showing 1-8 of 8
Last Updated: 09/26/2026